Skip to main content
Crossject logo

Crossject — Investor Relations & Filings

Ticker · ALCJ ISIN · FR0011716265 LEI · 969500W1VTFNL2D85A65 PA Manufacturing
Open in API
Filings indexed 355 across all filing types
Latest filing 2026-05-22 Share Issue/Capital Cha…
Country FR France
Listing PA ALCJ

About Crossject

https://www.crossject.com/en

Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.

Recent filings

Filing Released Lang Actions
CROSSJECT announces the successful completion of an equity financing and warrant issuance for a total immediate gross amount of €15 million
Share Issue/Capital Change Classification · 95% confidence The document is a press release announcing the successful completion of an equity financing via a capital increase and issuance of new shares and warrants. It provides details on the subscription price, share allotment, warrant terms, use of proceeds, and impact on share capital. This is not a full financial report, nor an AGM or earnings release, but rather an announcement of new share issuance (capital change) and fundraising. Therefore, it fits the Share Issue/Capital Change category (SHA).
2026-05-22 English
CROSSJCROSSJECT annonce le succès d’une augmentation de capital et d’une émission de bons de souscription d’actions (BSA) au profit d’investisseurs pour un montant de 15 millions d’euros
Share Issue/Capital Change Classification · 90% confidence The document is a press release announcing the successful completion of a capital increase through new share issuance and issuance of share subscription warrants (BSA), with full details on number of shares, subscription prices, warrants, exercise terms, and use of proceeds. This is not a full annual or interim report, nor a regulatory certification, but an announcement of new share issuance and capital structure change. This fits the definition of a Share Issue/Capital Change (SHA) filing.
2026-05-22 French
RAPPORT FINANCIER 2025
Annual Report
2026-04-30 French
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
Report Publication Announcement Classification · 95% confidence The document is a press release announcing that CROSSJECT has made available and filed its annual financial report for the year 2025 with the Autorité des Marchés Financiers (AMF), the French financial regulatory authority. The text states that the annual financial report can be consulted on the company's website, indicating that the report itself is not included in this document. The document length is short (1760 characters), and it primarily serves as a notification of the report's availability rather than containing the full annual report. According to the 'MENU VS MEAL' rule, such announcements should be classified as Report Publication Announcement (RPA), not as the Annual Report (10-K). Therefore, the correct classification is RPA with high confidence. FY 2025
2026-04-30 French
MISE A DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
Report Publication Announcement Classification · 95% confidence The document is a press release announcing that CROSSJECT has made its annual financial report for 2025 available to the public and filed it with the French financial regulator (Autorité des Marchés Financiers). The text states that the report can be consulted on the company's website but does not contain the actual report or financial data itself. The document length is only 1760 characters, which is quite short and consistent with an announcement rather than the full report. According to the 'Menu vs Meal' rule, this is a report publication announcement, not the annual report itself. FY 2025
2026-04-30 French
CROSSJECT nomme Lionel SELTZ au poste de Directeur Administratif et Financier
Board/Management Information Classification · 82% confidence The text is a corporate press release announcing the appointment of Lionel SELTZ as the new Chief Financial Officer, which is clearly a change in senior management. This fits the Board/Management Information category.
2026-03-25 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.